Lincoln Pharmaceuticals unveils Ondansetron oral spray in India

23 Sep 2016 Evaluate

Lincoln Pharmaceuticals has unveiled an Ondansetron oral spray, used for treatment of nausea and vomiting caused by surgery or cancer drugs, in the Indian market. The company has done bio-equivalent study for Ondansetron oral spray and has got the Drug Controller General of India (DCGI) permission. Ondansetron was earlier available as tablet, syrup and injectable in India. All India level the Anti-emetic drug market is Rs 678 crore and Ondansetron is one of the anti-emetic drug and all over India market is Rs 303 crore. Therefore, Ondansetron Spray is having very good market opportunity.

Lincoln Pharmaceuticals is a company is based at Ahmedabad and engaged in Manufacturing and Export of Pharmaceuticals formulations under various Therapeutic product group, plant duly complied with WHO-GMP guidelines. The Company is exporting more than 45 countries along with Domestic market in more than 20 states in India.

Lincoln Pharma Share Price

617.50 -0.15 (-0.02%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.